Profiles

Keywords
Last Name
Institution

Pauline Merrill

Concepts (89)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uveitis
5
2020
8
1.500
Why?
Uveitis, Posterior
3
2020
3
1.260
Why?
Sirolimus
3
2020
22
1.180
Why?
Posterior Eye Segment
2
2020
2
1.020
Why?
Macular Edema
1
2019
4
0.790
Why?
Immunologic Factors
1
2019
50
0.760
Why?
Rickettsia Infections
1
2016
1
0.630
Why?
Retinitis
1
2016
3
0.630
Why?
Eye Infections, Bacterial
1
2016
5
0.630
Why?
Visual Acuity
5
2020
47
0.510
Why?
Double-Blind Method
4
2020
550
0.450
Why?
Panuveitis
2
2020
2
0.410
Why?
Uveitis, Intermediate
2
2020
2
0.410
Why?
Immunosuppressive Agents
3
2020
167
0.390
Why?
Intravitreal Injections
4
2020
8
0.340
Why?
Female
11
2020
18107
0.300
Why?
Dose-Response Relationship, Drug
3
2020
527
0.280
Why?
Middle Aged
11
2020
11256
0.270
Why?
Adrenal Cortex Hormones
2
2016
99
0.260
Why?
Humans
16
2020
30741
0.260
Why?
Vision Disorders
2
2019
26
0.260
Why?
Tomography, Optical Coherence
2
2020
22
0.250
Why?
Choroid Diseases
1
2002
4
0.240
Why?
Time Factors
4
2020
1911
0.240
Why?
Retinal Diseases
1
2002
10
0.240
Why?
Treatment Failure
2
2020
188
0.240
Why?
Electronic Health Records
2
2019
77
0.220
Why?
Aged
8
2020
10156
0.220
Why?
Intraocular Pressure
1
2020
8
0.210
Why?
Databases, Factual
2
2019
372
0.200
Why?
Uveitis, Anterior
1
2019
5
0.200
Why?
Spondylarthropathies
1
2019
9
0.200
Why?
Follow-Up Studies
3
2020
2046
0.200
Why?
Anti-Inflammatory Agents
2
2020
109
0.200
Why?
Kaplan-Meier Estimate
1
2020
230
0.200
Why?
Proportional Hazards Models
1
2020
385
0.190
Why?
Treatment Outcome
5
2020
3850
0.190
Why?
Adult
8
2020
9760
0.190
Why?
International Classification of Diseases
1
2018
25
0.190
Why?
Male
9
2020
17552
0.190
Why?
Academic Medical Centers
1
2019
162
0.180
Why?
Retinal Necrosis Syndrome, Acute
2
2008
2
0.170
Why?
Retina
1
2016
17
0.170
Why?
Rickettsia
1
2016
1
0.160
Why?
Chorioretinitis
1
2016
3
0.160
Why?
HLA-A Antigens
1
2016
13
0.160
Why?
Africa
1
2016
12
0.160
Why?
Travel
1
2016
15
0.160
Why?
Retinal Neoplasms
1
2013
1
0.140
Why?
Antibodies, Monoclonal, Murine-Derived
1
2013
49
0.130
Why?
Lymphoma
1
2013
58
0.130
Why?
Ocular Hypotension
1
2012
1
0.120
Why?
Retrospective Studies
5
2020
3456
0.120
Why?
Antineoplastic Agents
1
2013
321
0.110
Why?
Eye Infections, Viral
1
2008
2
0.090
Why?
Drug Resistance, Viral
1
2008
43
0.090
Why?
AIDS-Related Opportunistic Infections
1
2008
49
0.090
Why?
Young Adult
3
2020
2249
0.070
Why?
Vasculitis, Central Nervous System
1
2004
3
0.070
Why?
Magnetic Resonance Angiography
1
2004
51
0.070
Why?
Prevalence
2
2019
546
0.070
Why?
Risk Factors
2
2019
2611
0.060
Why?
Aged, 80 and over
3
2020
5172
0.060
Why?
Exudates and Transudates
1
2002
1
0.060
Why?
Remission, Spontaneous
1
2002
11
0.060
Why?
Injections, Subcutaneous
1
2020
45
0.060
Why?
Women's Health
1
2002
220
0.050
Why?
Delayed Diagnosis
1
2019
13
0.050
Why?
Computer Systems
1
2018
6
0.050
Why?
Drug Evaluation, Preclinical
1
2018
39
0.050
Why?
Adolescent
2
2016
2627
0.040
Why?
Predictive Value of Tests
1
2019
631
0.040
Why?
Sensitivity and Specificity
1
2018
594
0.040
Why?
Clinical Trials as Topic
1
2018
386
0.040
Why?
Disease-Free Survival
1
2016
247
0.040
Why?
Chicago
1
2019
945
0.040
Why?
Prognosis
1
2019
1045
0.040
Why?
Reproducibility of Results
1
2018
875
0.040
Why?
Acute Disease
1
2016
272
0.040
Why?
Animals
2
2018
5221
0.040
Why?
Evidence-Based Medicine
1
2016
239
0.040
Why?
Diagnosis, Differential
1
2016
469
0.030
Why?
Chronic Disease
1
2016
542
0.030
Why?
Acyclovir
1
2008
6
0.020
Why?
Ganciclovir
1
2008
26
0.020
Why?
Immunocompromised Host
1
2008
56
0.020
Why?
Prednisone
1
2008
76
0.020
Why?
Drug Therapy, Combination
1
2008
266
0.020
Why?
Severity of Illness Index
1
2012
1233
0.020
Why?
Merrill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description